COIOSDeep risk insights through multi-disciplinary research across the globe
High-angle view of the Johannesburg skyline under a warm golden hour sky
Item confirms Peer-reviewed Added

Cancer risk in treated HIV followed age and smoking, not immune status

Among 7507 people with HIV on antiretroviral therapy, 219 cancers occurred over a median 5.6 years, with older age and current smoking associated with risk but immune markers not.

A secondary analysis of the REPRIEVE trial followed 7507 people with HIV on effective antiretroviral therapy for a median of 5.6 years. Cancer incidence was 5.6 per 1000 person-years, with prostate, breast, lung and anal the leading cancers. Older age, residence in a high-income country and current smoking were associated with higher risk, whereas sex, body mass index and CD4-based measures were not.

Why it is interesting: In treated HIV, cancer risk now tracks age, region and smoking rather than immune status.

Source
AIDS, 18 September 2026
Paper
Cancer incidence and risk factors among people with HIV in REPRIEVE
Authors
Zhao S, McCallum S, Awwad A, Castle PE, Diggs MR, Zanni MV et al.
DOI
10.1097/qad.0000000000004625
Type
Peer-reviewed article
Design
Secondary analysis of the REPRIEVE randomised trial cohort, 7507 people with HIV on ART, median 5.6 years' follow-up, 219 incident cancers
Verdict
Confirms prior evidence
Driver
Cancer
Driver
Smoking and vaping

Other drivers in Health today